KINERGI MED
The computed 12-month bankruptcy probability of KINERGI MED is 0.1% (very low). The 2024 annual accounts show equity of €346k and a net result of €30k. Equity is growing by ~9.4% per year across the filed fiscal years. The company has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €346k |
| Net result | €30k |
| Active | 26 yrs |
| Locations | 2 |
Exceptional profile — strong across almost every axis.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €36k |
| Net profit | €30k |
| Cash flow | €34k |
| Staff costs | — |
| Income taxes | €4k |
| Dividends | — |
| Total assets | €379k |
| Equity | €346k |
| Debt | €33k |
| of which ≤ 1y | €33k |
| of which > 1y | — |
| Working capital | €278k |
| Employees (FTE) | — |
| 2024 | |
|---|---|
| Current ratio | 9.44 |
| Quick ratio | 9.44 |
| Working capital ratio | 73.2% |
| Solvency | 91.3% |
| Debt / equity | 0.09 |
| Long-term debt ratio | — |
| Interest coverage | 234.65 |
| Gross margin | — |
| Net margin | — |
| ROA | 8.0% |
| ROE | 8.7% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €379k |
| Fixed assets | 21/28 | €69k |
| Tangible fixed assets | 22/27 | €69k |
| Current assets | 29/58 | €310k |
| Amounts receivable within one year | 40/41 | €59k |
| Cash & bank | 54/58 | €251k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €379k |
| Equity | 10/15 | €346k |
| Contributions / capital | 10/11 | €14k |
| Reserves | 13 | €72k |
| Accumulated profits (losses) | 14 | €261k |
| Amounts payable | 17/49 | €33k |
| Amounts payable within one year | 42/48 | €33k |
| Income statement | ||
| Gross operating margin | 9900 | €36k |
| Operating result | 9901 | €32k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €152 |
| Result before taxes | 9903 | €34k |
| Income taxes | 67/77 | €4k |
| Net result for the period | 9904 | €30k |
| Result to be appropriated | 9905 | €30k |
| NACE primary | General medical practice(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 08-02-2000 |
| Status | Active |
| Postal code | 1070 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21492B0083/00K009 | Brussels | 836 m² | 1 · 965 m² | 21.9 m · 1 fl. |
| 21012A0169/00D009 | Brussels | 503 m² | 1 · 302 m² | 15.9 m · 4 fl. |
| 21308H0521/00F002 | Brussels | 272 m² | 1 · 133 m² | 12.1 m · 2 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
27-12-2022 2 directors appointed
- M. Mohamed Tejeddine ISMAIL — Commissaris
- M. Ayyoub ISMAIL — Zaakvoerder
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "M. Mohamed Tejeddine ISMAIL",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "secretaris",
"person": {
"rrn": null,
"name": "M. Bilal ISMAIL",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale donne procuration au secr\u00E9taire M. Bilal ISMAIL pour le d\u00E9p\u00F4t et la publication du proc\u00E8s-verbal.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "gerant",
"person": {
"rrn": null,
"name": "M. Ayyoub ISMAIL",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article des statuts, le pr\u00E9sident souhaite nommer M. Ayyoub ISMAIL, comme co-g\u00E9rant de la soci\u00E9t\u00E9.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2022-12-15",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-12-05",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0470.573.427",
"name_full": "KINERGI MED",
"legal_form": "SPRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "M. Mohamed Tejeddine ISMAIL",
"org_rep_person_name": null,
"person_role_at_subject": "Pr\u00E9sident de I\u0027A.G extra"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | KINERGI MED |